DFNSVSGTBP• 12 Months (Normalized)
DFNS vs GTBP (T3 Defense Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DFNS Performance $6.7
-99.34%
T3 Defense Inc.
Normalized Baseline0.00%
GTBP Performance $6.37
+747.07%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-846.41 pts
GTBP outperforming by 846.41 percentage points
DFNSGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DFNS GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | DFNS Price | DFNS Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $6.70 | -99.34% | $6.37 | +747.07% | -846.41% |
| Oct 05, 2026 | $6.78 | -99.33% | $6.16 | +719.15% | -818.48% |
| Oct 02, 2026 | $7.34 | -99.28% | $6.10 | +711.17% | -810.45% |
| Sep 29, 2026 | $- | $6.88 | +814.23% | - | |
| Sep 28, 2026 | $- | $6.80 | +804.26% | - | |
| Sep 25, 2026 | $7.79 | -99.23% | $6.89 | +816.22% | -915.45% |
| Sep 24, 2026 | $7.87 | -99.23% | $6.83 | +808.24% | -907.47% |
| Sep 23, 2026 | $7.87 | -99.23% | $7.10 | +844.15% | -943.38% |
| Sep 22, 2026 | $8.35 | -99.18% | $- | - | |
| Sep 21, 2026 | $8.20 | -99.19% | $7.18 | +854.79% | -953.98% |
| Sep 18, 2026 | $7.66 | -99.25% | $7.16 | +852.13% | -951.38% |
| Sep 17, 2026 | $7.88 | -99.23% | $7.49 | +896.01% | -995.24% |
| Sep 16, 2026 | $7.68 | -99.25% | $7.81 | +938.56% | -1037.81% |
| Sep 15, 2026 | $8.28 | -99.19% | $9.00 | +1096.81% | -1196.00% |
| Sep 14, 2026 | $9.23 | -99.09% | $11.63 | +1446.54% | -1545.63% |
Page 1 of 17